{
    "nctId": "NCT03517332",
    "briefTitle": "Circulating Tumor DNA Exposure in Peripheral Blood",
    "officialTitle": "Circulating Tumor DNA Exposure in Peripheral Blood Using a Novel Process: A Feasibility Study",
    "overallStatus": "UNKNOWN",
    "conditions": "Colorectal Cancer, Pancreatic Adenocarcinoma, Gastric Cancer, Hepatocellular Carcinoma, Non-small Cell Lung Cancer, Bladder Cancer, Melanoma, Ovarian Cancer, Adrenocortical Cancer, Breast Cancer, Other Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 10000,
    "primaryOutcomeMeasure": "Circulating tumor DNA exposure in peripheral blood using a novel process: A feasibility study",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* This study will include subjects that are diagnosed with a malignancy (cohort\n\n  1) and a negative cohort with subjects that have not been diagnosed with a malignancy (cohort 2).\n* Subjects of both cohorts must:\n\n  * Be of age \u2265 18\n  * Provide written consent for study participation\n* Subject of cohort 1 must:\n\n  * Have a diagnosis of a malignancy in clinical stage 0 to IV including but not limited to: colon or rectal cancer, pancreatic and gastric cancer, hepatocellular carcinoma, non-small cell lung cancer, bladder cancer, melanoma\n\nSubjects of cohort 2 must:\n\n\u2022 Meet the listed matching criteria\n\nExclusion Criteria:\n\n* Subjects of cohort 1 must not: Have been treated for above diagnosed malignancy\n* Subjects of cohort 2 must not:\n\n  * Have been diagnosed/treated for a malignancy previously",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}